Details for New Drug Application (NDA): 063295
✉ Email this page to a colleague
The generic ingredient in MONOCID is cefonicid sodium. Additional details are available on the cefonicid sodium profile page.
Summary for 063295
Tradename: | MONOCID |
Applicant: | Glaxosmithkline |
Ingredient: | cefonicid sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063295
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Jul 26, 1993 | TE: | RLD: | No |
Complete Access Available with Subscription